000 | 01071 a2200313 4500 | ||
---|---|---|---|
005 | 20250513093829.0 | ||
264 | 0 | _c19961113 | |
008 | 199611s 0 0 eng d | ||
022 | _a0012-6667 | ||
024 | 7 |
_a10.2165/00003495-199600511-00008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRubinstein, E | |
245 | 0 | 0 |
_aFuture prospects and therapeutic potential of streptogramins. _h[electronic resource] |
260 |
_bDrugs _c1996 |
||
300 |
_a38-42 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aBacteremia _xmicrobiology |
650 | 0 | 4 | _aForecasting |
650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xepidemiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aMethicillin Resistance |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 |
_aVirginiamycin _xtherapeutic use |
700 | 1 | _aKeller, N | |
773 | 0 |
_tDrugs _gvol. 51 Suppl 1 _gp. 38-42 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2165/00003495-199600511-00008 _zAvailable from publisher's website |
999 |
_c8721967 _d8721967 |